A tiered decisional framework for genetic epileptic syndromes with or without encephalopathies: from standard care to investigational strategies

Progress depends on early etiological diagnosis and timely, mechanism-informed therapy. Future advances require expanded genomic testing, natural history studies, mechanism-based biomarkers, and innovative trial designs tailored to complex pediatric populations.